StockData
GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc. (GDRX) stock

GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)

Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –

GoodRx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

GoodRx's pe ratio was 91.3× on Nov 11, 2026, against 31.2× a year earlier. Over the last 3 years it ranged from 20.8× to 555.5×, with a median of 87.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202691.3×+61.1
2025Dec 31, 202530.1×−119.9
2024Jan 31, 2024150.0×−17.5
2023Dec 29, 2023167.5×−388.0
2021Jan 29, 2021555.5×+74.8
2020Dec 31, 2020480.6×–

More GoodRx figures

See a number that looks wrong?